New York, NYNCT07300904Now EnrollingIRB Ready

Overactive Bladder (OAB) Clinical Trial in New York, NY

Access cutting-edge overactive bladder (oab) treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Stimuli Technology

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access overactive bladder (oab) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related overactive bladder (oab) treatment provided free

Apply for This New York Location

Check if you qualify for this overactive bladder (oab) clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Overactive Bladder (OAB) Study in New York

The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.

Sponsor: Stimuli Technology

Who Can Participate

Inclusion Criteria

Adult subjects aged 22 years or older and,
Diagnosed with OAB symptoms (characterized by urinary urgency, with or without UUI),
Symptoms persisting for at least 3 months, and
Documented with 2 or more urgency episodes per day (with or without incontinence) in two 3-day bladder diaries and,
With at least 11 or more voids per day (urinary frequency) documented in two 3-day bladder diaries
Willing and capable of providing informed consent
Capable of participating in all testing associated with this clinical investigation

Exclusion Criteria

Patients with pacemakers or implanted defibrillators or any other implanted electronic device
Patients prone to excessive bleeding
Patients with nerve damage that could impact the percutaneous tibial nerve or pelvic floor function
Patients who are pregnant or planning to become pregnant while using this product
Patients with ankle joint problems, ankle oedema or dermatological oedema in the area where the electrodes should be placed
Patients wearing a metal implant near the stimulated area
Patient with cognitive deficiency
Administration of intravesical injection of botulinum toxin within 12 months of study enrollment, or treatment within the previous year with other forms neuromodulation for OAB
Patients treated with medical therapy OAB treatment washout inferior to 30 days
Patients with diabetic neuropathy
Patients with uncontrolled diabetes and HbA1c levels above 7%
Guillain-Barré syndrome
Chronic inflammatory demyelinating polyneuropathy (CIDP)
Multiple sclerosis
A primary diagnosis of stress urinary incontinence (SUI)
Patients with recurrent rrinary tract infections (UTIs) defined as more than 2 episodes per year, or with any baseline lower urinary tract pathology identified at the time of the 3-day bladder diary assessment.
Currently participating in another clinical trial

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07300904) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Overactive Bladder (OAB) Treatment Options in New York, NY

If you're searching for overactive bladder (oab) treatment options in New York, NY, this clinical trial (NCT07300904) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced overactive bladder (oab) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all overactive bladder (oab) clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in New York, NY

See all alzheimers disease clinical trials recruiting in New York — not just this study.

Browse Alzheimers Disease Trials in New York →

Browse More Trials by Condition

Alzheimers Disease TrialsADHD TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsOveractive Bladder TrialsOsteoarthritis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY